Renaissance Technologies LLC Boosts Holdings in DocGo Inc. (NASDAQ:DCGO)

Renaissance Technologies LLC increased its position in DocGo Inc. (NASDAQ:DCGO - Free Report) by 583.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 350,600 shares of the company's stock after purchasing an additional 299,300 shares during the quarter. Renaissance Technologies LLC owned 0.34% of DocGo worth $1,487,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Prudential Financial Inc. purchased a new position in DocGo in the 4th quarter valued at about $55,000. Royce & Associates LP acquired a new position in shares of DocGo in the fourth quarter worth about $64,000. Intech Investment Management LLC boosted its holdings in DocGo by 76.7% in the fourth quarter. Intech Investment Management LLC now owns 32,834 shares of the company's stock valued at $139,000 after purchasing an additional 14,247 shares during the last quarter. SG Americas Securities LLC grew its stake in DocGo by 12.9% during the 4th quarter. SG Americas Securities LLC now owns 43,052 shares of the company's stock valued at $183,000 after purchasing an additional 4,905 shares in the last quarter. Finally, EntryPoint Capital LLC purchased a new stake in DocGo during the 4th quarter worth approximately $203,000. 56.44% of the stock is owned by institutional investors and hedge funds.

DocGo Price Performance

DCGO stock opened at $2.24 on Tuesday. The firm has a market cap of $228.44 million, a price-to-earnings ratio of 8.00, a PEG ratio of 14.16 and a beta of 1.12. DocGo Inc. has a 1-year low of $2.02 and a 1-year high of $5.68. The firm has a fifty day moving average price of $2.83 and a two-hundred day moving average price of $3.76.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on DCGO shares. Stifel Nicolaus reduced their target price on DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a research note on Friday, February 28th. Deutsche Bank Aktiengesellschaft downgraded shares of DocGo from a "buy" rating to a "hold" rating and reduced their price objective for the company from $5.00 to $2.85 in a research note on Friday, February 28th. Finally, Needham & Company LLC reissued a "buy" rating and issued a $4.00 target price on shares of DocGo in a research report on Tuesday, April 8th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $4.89.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Want to see what other hedge funds are holding DCGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocGo Inc. (NASDAQ:DCGO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.